Representing the SMART study investigator group. Consolidation therapy with intraperitoneal R1549 (yttrium-90-labeled HMFG1 murine monoclonal antibody) in epithelial ovarian cancer: a phase III trial

RHM Verheijen; M.V. Seiden; BB Benigno; LFAG Massuger; A. Lopes; JT Soper; J. Markowska; R Vyzula; H. Lambert; AA Epenetos

Representing the SMART study investigator group. Consolidation therapy with intraperitoneal R1549 (yttrium-90-labeled HMFG1 murine monoclonal antibody) in epithelial ovarian cancer: a phase III trial

RHM Verheijen, M.V. Seiden, BB Benigno, LFAG Massuger, A. Lopes, JT Soper, J. Markowska, R Vyzula, H. Lambert, AA Epenetos

Research output: Contribution to conference › Abstract › Other research output

Original language	English
Publication status	Published - 2004
Event	Hammersmith Meeting - Cap Sounio, Greece Duration: 27 Jun 2004 → 30 Jun 2004

Conference

Conference	Hammersmith Meeting
Country/Territory	Greece
City	Cap Sounio
Period	27/06/04 → 30/06/04

Cite this

Verheijen, RHM., Seiden, M. V., Benigno, BB., Massuger, LFAG., Lopes, A., Soper, JT., Markowska, J., Vyzula, R., Lambert, H., & Epenetos, AA. (2004). Representing the SMART study investigator group. Consolidation therapy with intraperitoneal R1549 (yttrium-90-labeled HMFG1 murine monoclonal antibody) in epithelial ovarian cancer: a phase III trial. Abstract from Hammersmith Meeting, Cap Sounio, Greece.

@conference{bbd98bd7dd354fff85ba047068b4676d,

title = "Representing the SMART study investigator group. Consolidation therapy with intraperitoneal R1549 (yttrium-90-labeled HMFG1 murine monoclonal antibody) in epithelial ovarian cancer: a phase III trial",

author = "RHM Verheijen and M.V. Seiden and BB Benigno and LFAG Massuger and A. Lopes and JT Soper and J. Markowska and R Vyzula and H. Lambert and AA Epenetos",

year = "2004",

language = "English",

note = "Hammersmith Meeting ; Conference date: 27-06-2004 Through 30-06-2004",

}

Verheijen, RHM, Seiden, MV, Benigno, BB, Massuger, LFAG, Lopes, A, Soper, JT, Markowska, J, Vyzula, R, Lambert, H & Epenetos, AA 2004, 'Representing the SMART study investigator group. Consolidation therapy with intraperitoneal R1549 (yttrium-90-labeled HMFG1 murine monoclonal antibody) in epithelial ovarian cancer: a phase III trial', Hammersmith Meeting, Cap Sounio, Greece, 27/06/04 - 30/06/04.

Representing the SMART study investigator group. Consolidation therapy with intraperitoneal R1549 (yttrium-90-labeled HMFG1 murine monoclonal antibody) in epithelial ovarian cancer: a phase III trial. / Verheijen, RHM; Seiden, M.V.; Benigno, BB et al.
2004. Abstract from Hammersmith Meeting, Cap Sounio, Greece.

Research output: Contribution to conference › Abstract › Other research output

TY - CONF

T1 - Representing the SMART study investigator group. Consolidation therapy with intraperitoneal R1549 (yttrium-90-labeled HMFG1 murine monoclonal antibody) in epithelial ovarian cancer: a phase III trial

AU - Verheijen, RHM

AU - Seiden, M.V.

AU - Benigno, BB

AU - Massuger, LFAG

AU - Lopes, A.

AU - Soper, JT

AU - Markowska, J.

AU - Vyzula, R

AU - Lambert, H.

AU - Epenetos, AA

PY - 2004

Y1 - 2004

M3 - Abstract

T2 - Hammersmith Meeting

Y2 - 27 June 2004 through 30 June 2004

ER -